At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine. Every year, our products reach approximately 500 million patients.
In addition to top global rankings in biosimilars1 and generic antibiotics2, Sandoz holds strong global positions in areas ranging from generic cardiovascular, central nervous system (CNS), pain and ophthalmology to oncology and respiratory.
Our broad portfolio is backed by a range of state-of-the-art technologies, formulations and devices, including prolonged-release and multiple-unit tablets, creams and gels, orodispersible films, transdermal patches, lyophilized products, implants and inhalers.